T44.7X1D Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter

Name of the Condition

• Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
• This code applies to accidental poisoning by beta-adrenoreceptor antagonists (beta-blockers) during a subsequent encounter for care.

Summary

This code describes accidental poisoning by beta-adrenoreceptor antagonists, where the exposure was unintentional, and the patient is receiving follow-up care. Beta-blockers are medications used to manage cardiovascular conditions, and accidental poisoning may occur due to dosing errors, misuse, or environmental exposure.

Causes

Accidental poisoning by beta-adrenoreceptor antagonists typically results from unintentional overdose, incorrect administration, or exposure to these medications through mishandling or environmental sources. This may include taking the wrong dose, using someone else’s medication, or accidental ingestion by children or vulnerable individuals.

Risk Factors

• Concurrent use of multiple cardiovascular medications.
• Pre-existing conditions affecting drug metabolism (e.g., liver or kidney disease).
• Age-related changes in drug sensitivity (e.g., elderly or pediatric patients).
• History of cognitive impairment or medication non-adherence.

Symptoms

• Bradycardia (slow heart rate) or tachycardia (rapid heart rate).
• Fatigue, dizziness, or syncope.
• Hypotension or cold extremities.
• Respiratory distress or wheezing.
• Confusion or altered mental status.

Diagnosis

Diagnosis involves assessing symptoms consistent with beta-blocker toxicity, reviewing the patient’s medication history, and confirming exposure through clinical evaluation. Vital signs, electrocardiogram (EKG), and laboratory tests may be used to evaluate cardiovascular and metabolic effects.

Treatment Options

Treatment focuses on stabilizing the patient, supporting vital functions, and managing symptoms. This may include monitoring, administration of antidotes (e.g., glucagon), and supportive care such as intravenous fluids or medications to address bradycardia or hypotension.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Subsequent encounters require ongoing monitoring to assess recovery and prevent recurrence. Follow-up care may involve medication adjustments, patient education, or referrals to specialists.

Complications

• Prolonged bradycardia or heart block.
• Hypotension leading to shock.
• Respiratory failure or aspiration.
• Neurological deficits from cerebral hypoperfusion.

Lifestyle & Prevention

• Store medications securely to prevent accidental access.
• Use childproof containers and follow dosing instructions carefully.
• Educate patients and caregivers on proper medication handling.
• Avoid mixing beta-blockers with alcohol or other sedatives.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, such as severe dizziness, fainting, difficulty breathing, or altered consciousness. Follow-up care is necessary for ongoing symptoms or concerns about medication safety.

Tips for Medical Coders

This code is for accidental (unintentional) poisoning by beta-adrenoreceptor antagonists during a subsequent encounter. Document the unintentional nature of the exposure and the subsequent care provided. Ensure clinical documentation supports the diagnosis and encounter type to justify code assignment.